Primary coronary microvascular dysfunction and poor coronary collaterals predict post-percutaneous coronary intervention cardiac necrosis

Coronary Artery Disease

Volumn 20, Issue 4, 2009, Pages 253-259

  Hoole, Stephen P ^a   White, Paul A ^a   Heck, Patrick M ^a   Khan, Sadia N ^a   Densem, Cameron G ^a   Clarke, Sarah C ^a   Shapiro, Leonard M ^a   Schofield, Peter M ^a   O'Sullivan, Michael ^a   Dutka, David P ^a,b  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Cardiac troponin l; Coronary collaterals; Elective percutaneous coronary intervention; Microvascular dysfunction

Indexed keywords

TROPONIN I;

ADULT; ANGIOCARDIOGRAPHY; AORTA PRESSURE; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY COLLATERAL CIRCULATION; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY PRESSURE; CORONARY HEMODYNAMICS; CORONARY VASCULAR RESISTANCE; DISEASE ASSOCIATION; DOPPLER FLOWMETRY; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE NECROSIS; HUMAN; MALE; MICROANGIOPATHY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STENT;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BIOLOGICAL MARKERS; BLOOD FLOW VELOCITY; BLOOD PRESSURE; COLLATERAL CIRCULATION; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; CORONARY STENOSIS; ECHOCARDIOGRAPHY, DOPPLER, COLOR; HUMANS; MALE; MICROCIRCULATION; MIDDLE AGED; MODELS, CARDIOVASCULAR; MYOCARDIUM; NECROSIS; PREDICTIVE VALUE OF TESTS; TIME FACTORS; TREATMENT OUTCOME; TROPONIN I; UP-REGULATION; VASCULAR RESISTANCE;

EID: 67649641630     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCA.0b013e32832ac5ac     Document Type: Article

References (36)

1. Selvanayagam JB, Porto I, Channon K, Petersen SE, Francis JM, Neubauer S, et al. Troponin elevation after percutaneous coronary intervention directly represents the extent of irreversible myocardial injury: insights from cardiovascular magnetic resonance imaging. Circulation 2005; 111:1027-1032.
2. Nageh T, Sherwood RA, Harris BM, Byrne JA, Thomas MR. Cardiac troponin Tand I and creatine kinase-MB as markers of myocardial injury and predictors of outcome following percutaneous coronary intervention. Int J Cardiol 2003; 92:285-293.
3. Kizer JR, Muttrej MR, Matthai WH, McConnell J, Nardone H, Sonel AF, et al. Role of cardiac troponin T in the long-term risk stratification of patients undergoing percutaneous coronary intervention. Eur Heart J 2003; 24:1314-1322.
4. Ricciardi MJ, Davidson CJ, Gubernikoff G, Beohar N, Eckman LJ, Parker MA, ef al. Troponin I elevation and cardiac events after percutaneous coronary intervention. Am Heart J 2003; 145:522-528.
5. Bahrmann P, Werner GS, Heusch G, Ferrari M, Poerner TC, Voss A, et al. Detection of coronary microembolization by Doppler ultrasound in patients with stable angina pectoris undergoing elective percutaneous coronary interventions. Circulation 2007; 115:600-608.
6. Herrmann J, Haude M, Lerman A, Schulz R, Volbracht L, Ge J, ef al. Abnormal coronary flow velocity reserve after coronary intervention is associated with cardiac marker elevation. Circulation 2001; 103:2339-2345.
7. Kjaer A, Meyer C, Nielsen FS, Parving HH, Hesse B. Dipyridamole, cold pressor test, and demonstration of endothelial dysfunction: a PET study of myocardial perfusion in diabetes. J Nucl Med 2003; 44:19-23.
8. Sabia PJ, Powers ER, Ragosta M, Sarembock IJ, Burwell LR, Kaul S. An association between collateral blood flow and myocardial viability in patients with recent myocardial infarction. N Engl J Med 1992; 327:1825-1831.
9. Antoniucci D,Valenti R, Moschi G, Migliorini A.Trapani M, Santoro GM, et al. Relation between preintervention angiographic evidence of coronary collateral circulation and clinical and angiographic outcomes after primary angioplasty or stenting for acute myocardial infarction. Am J Cardiol 2002; 89:121-125.
10. Werner GS, Richartz BM, Gastmann O, Ferrari M, Figulla HR. Immediate changes of collateral function after successful recanalization of chronic total coronary occlusions. Circulation 2000; 102:2959-2965.
11. Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. Eur Heart J 2000; 21:1502-1513.
12. Cuisset T, Hamilos M, Melikian N, Wyffels E, Sanma J, Sarno G, et al. Direct stenting for stable angina pectoris is associated with reduced periprocedural microcirculatory injury compared with stenting after pre-dilation. J Am Coll Cardiol 2008; 51:1060-1065.
13. Verhoeff BJ, Siebes M, Meuwissen M, Atasever B, Voskuil M, de Winter RJ, et al. Influence of percutaneous coronary intervention on coronary microvascular resistance index. Circulation 2005; 111:76-82.
14. Albertal M, Voskuil M, Piek JJ, de Bruyne B, Van Langenhove G, Kay PI, ef al. Coronary flow velocity reserve after percutaneous interventions is predictive of periprocedural outcome. Circulation 2002; 105:1573-1578.
15. Prasad A, Stone GW, Stuckey TD, Costantini CO, Zimetbaum PJ, McLaughlin M, ef al. Impact of diabetes mellitus on myocardial perfusion after primary angioplasty in patients with acute myocardial infarction. J Am Coll Cardiol 2005; 45:508-514.
16. Knudson JD, Dincer UD, Bratz IN, Sturek M, Dick GM.Tune JD. Mechanisms of coronary dysfunction in obesity and insulin resistance. Microcirculation 2007; 14:317-338.
17. Stokes KY, Cooper D, Tailor A, Granger DN. Hypercholesterolemia promotes inflammation and microvascular dysfunction: role of nitric oxide and superoxide. Free Radio Biol Med 2002; 33:1026-1036.
18. Kozakova M, Palombo C, Pratali L, Pittella G, Galetta F, L'Abbate A. Mechanisms of coronary flow reserve impairment in human hypertension. An integrated approach by transthoracic and transesophageal echocardiography. Hypertension 1997; 29:551-559.
19. Celik T, Turhan H, Kursaklioglu H, lyisoy A, Yuksel UC, Ozmen N, ef al. Impact of metabolic syndrome on myocardial perfusion grade after primary percutaneous coronary intervention in patients with acute ST elevation myocardial infarction. Coron Artery Dis 2006; 17:339-343.
20. Clavijo LC, Pinto TL, Kuchulakanti PK, Torguson R, Chu WW, Satler LF, ef al. Metabolic syndrome in patients with acute myocardial infarction is associated with increased infarct size and in-hospital complications. Cardiovasc Revasc Med 2006; 7:7-11.
21. Gick M, Jander N, Bestehorn HP, Kienzle RP, Ferenc M, Werner K, et al. Randomized evaluation of the effects of filter-based distal protection on myocardial perfusion and infarct size after primary percutaneous catheter intervention in myocardial infarction with and without ST-segment elevation. Circulation 2005; 112:1462-1469.
22. Stone GW, Webb J, Cox DA, Brodie BR, Qureshi M, Kalynych A, ef al. Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trial. JAMA 2005; 293:1063-1072.
23. De Marchi SF, Oswald P, Windecker S, Meier B, Seiler C. Reciprocal relationship between left ventricular filling pressure and the recruitable human coronary collateral circulation. Eur Heart J 2005; 26:558-566.
24. Iwado Y, Yoshinaga K, Furuyama H, Ito Y, Noriyasu K, Katoh C, ef al. Decreased endothelium-dependent coronary vasomotion in healthy young smokers. Eur J Nucl Med Mol Imaging 2002; 29:984-990.
25. Pepine CJ, Schlaifer JD, Mancini GB, Pitt B, O'Neill BJ, Haber HE. Influence of smoking status on progression of endothelial dysfunction. TREND investigators. Trial on Reversing Endothelial Dysfunction. Clin Cardiol 1998; 21:331-334.
26. Nitenberg A, Antony I, Foult JM. Acetylcholine-induced coronary vasoconstriction in young, heavy smokers with normal coronary arteriographio findings. Am J Med 1993; 95:71-77.
27. Hori M, Inoue M, Kitakaze M, Koretsune Y, Iwai K, Tamai J, et al. Role of adenosine in hyperemic response of coronary blood flow in microembolization. Am J Physiol 1986; 250:H509-H518.
28. Gregorini L, Marco J, Farah B, Bernies M, Palombo C, Kozakova M, et al. Effects of selective alphal - and alpha2-adrenergic blockade on coronary flow reserve after coronary stenting. Circulation 2002; 106:2901-2907.
29. Meier P, Gloekler S, Zbinden R, Beckh S, de Marchi SF, Zbinden S, et al. Beneficial effect of reoruitable collaterals: a 10-year follow-up study in patients with stable coronary artery disease undergoing quantitative collateral measurements. Circulation 2007; 116:975-983.
30. Rentrop KP, Cohen M, Blanke H, Phillips RA. Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol 1985; 5:587-592.
31. Piek JJ, van Liebergen RA, Koch KT, Peters PJ, David GK. Clinical, angiographic and hemodynamic predictors of recruitable collateral flow assessed during balloon angioplasty coronary occlusion. J Am Coll Cardiol 1997; 29:275-282.
32. Cribier A, Korsatz L, Koning R, Rath P, Gamra H, Stix G, et al. Improved myocardial ischemic response and enhanced collateral circulation with long repetitive coronary occlusion during angioplasty: a prospective study. J Am Coll Cardiol 1992; 20:578-586.
33. Billinger M, Fleisch M, Eberli FR, Garachemani A, Meier B, Seiler C. Is the development of myocardial tolerance to repeated ischemia in humans due to preconditioning or to collateral recruitment? J Am Coll Cardiol 1999; 33:1027-1035.
34. Mason MJ, Walker SK, Patel DJ, Paul VE, llsley CD. Influence of clinical and angiographic factors on development of collateral channels. Coron Artery Dis 2000; 11:573-578.
35. Siebes M, Verhoeff BJ, Meuwissen M, de Winter RJ, Spaan JA, Piek JJ. Single-wire pressure and flow velocity measurement to quantify coronary stenosis hemodynamics and effects of percutaneous interventions. Circulation 2004; 109:756-762.
36. Seiler C, Fleisch M, Garachemani A, Meier B. Coronary collateral quantitation in patients with coronary artery disease using intravascular flow velocity or pressure measurements. J Am Coll Cardiol 1998; 32:1272-1279.